Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$51.23
-3.55-6.48%
At close: -
$51.23
0.000.00%
After Hours: Apr 4, 4:00 PM EDT
Comments
Loading...
PROCEPT BioRobotics Analyst Ratings and Price Targets | NASDAQ:PRCT | Benzinga
PROCEPT BioRobotics Corp has a consensus price target of $78.8 based on the ratings of 12 analysts. The high is $112 issued by Wells Fargo on December 3, 2024. The low is $37 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by Morgan Stanley, Truist Securities, and Wells Fargo on February 26, 2025, February 26, 2025, and December 3, 2024, respectively. With an average price target of $99 between Morgan Stanley, Truist Securities, and Wells Fargo, there's an implied 93.25% upside for PROCEPT BioRobotics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Truist Securities
Wells Fargo
Jefferies
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for PROCEPT BioRobotics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | Buy Now | 85.44% | Morgan Stanley | Patrick Wood51% | $105 → $95 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 75.68% | Truist Securities | Richard Newitter73% | $105 → $90 | Reiterates | Buy → Buy | Get Alert |
| 12/03/2024 | Buy Now | 118.62% | Wells Fargo | Nathan Treybeck55% | → $112 | Reinstates | Overweight → Overweight | Get Alert |
| 12/02/2024 | Buy Now | 104.96% | Morgan Stanley | Patrick Wood51% | → $105 | Initiates | → Overweight | Get Alert |
| 11/14/2024 | Buy Now | 85.44% | Jefferies | Michael Sarcone10% | → $95 | Initiates | → Hold | Get Alert |
| 10/30/2024 | Buy Now | 104.96% | Truist Securities | Richard Newitter73% | $95 → $105 | Reiterates | Buy → Buy | Get Alert |
| 10/08/2024 | Buy Now | 46.4% | Piper Sandler | Matt O'Brien51% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | 93.25% | TD Cowen | Joshua Jennings53% | $75 → $99 | Maintains | Buy | Get Alert |
| 09/03/2024 | Buy Now | 85.44% | Truist Securities | Richard Newitter73% | $74 → $95 | Maintains | Buy | Get Alert |
| 08/22/2024 | Buy Now | 83.49% | B of A Securities | Craig Bijou76% | $80 → $94 | Maintains | Buy | Get Alert |
| 08/02/2024 | Buy Now | 34.69% | Wells Fargo | Nathan Treybeck55% | $67 → $69 | Maintains | Overweight | Get Alert |
| 08/02/2024 | Buy Now | 44.45% | Truist Securities | Richard Newitter73% | $79 → $74 | Reiterates | Buy → Buy | Get Alert |
| 07/16/2024 | Buy Now | 54.21% | Truist Securities | Richard Newitter73% | $72 → $79 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 46.4% | TD Cowen | Joshua Jennings53% | $65 → $75 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 46.4% | Piper Sandler | Matt O'Brien51% | $67 → $75 | Maintains | Overweight | Get Alert |
| 05/02/2024 | Buy Now | 40.54% | Truist Securities | Richard Newitter73% | $63 → $72 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 13.21% | Truist Securities | Richard Newitter73% | $55 → $58 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | -8.26% | Wells Fargo | Nathan Treybeck55% | $44 → $47 | Maintains | Overweight | Get Alert |
| 12/22/2023 | Buy Now | -2.4% | Truist Securities | Richard Newitter73% | $48 → $50 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | -14.11% | Wells Fargo | Nathan Treybeck55% | $40 → $44 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -27.78% | Leerink Partners | Mike Kratky64% | → $37 | Initiates | → Outperform | Get Alert |
| 09/13/2023 | Buy Now | -4.35% | Truist Securities | Richard Newitter73% | → $49 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | -18.02% | Piper Sandler | Matt O'Brien51% | → $42 | Initiates | → Overweight | Get Alert |
| 05/31/2023 | Buy Now | — | William Blair | Brandon Vazquez54% | — | Initiates | → Outperform | Get Alert |
| 05/01/2023 | Buy Now | -4.35% | Truist Securities | Richard Newitter73% | $54 → $49 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | -8.26% | Keybanc | Matthew Mishan53% | $48 → $47 | Maintains | Overweight | Get Alert |
| 04/28/2023 | Buy Now | -14.11% | B of A Securities | Craig Bijou76% | $52 → $44 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | -4.35% | Truist Securities | Richard Newitter73% | $54 → $49 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 7.36% | Truist Securities | Richard Newitter73% | $58 → $55 | Maintains | Buy | Get Alert |
| 01/12/2023 | Buy Now | -16.06% | Wells Fargo | Nathan Treybeck55% | $52 → $43 | Maintains | Overweight | Get Alert |
| 12/12/2022 | Buy Now | 1.5% | Wells Fargo | Nathan Treybeck55% | $49 → $52 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | -14.11% | Goldman Sachs | Amit Hazan56% | $39 → $44 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | -6.3% | Keybanc | Matthew Mishan53% | $47 → $48 | Maintains | Overweight | Get Alert |
| 10/31/2022 | Buy Now | — | BTIG | Ryan Zimmerman72% | — | Initiates | → Neutral | Get Alert |
| 10/25/2022 | Buy Now | 13.21% | Truist Securities | Richard Newitter73% | → $58 | Initiates | → Buy | Get Alert |
| 09/02/2022 | Buy Now | -4.35% | Wells Fargo | Nathan Treybeck55% | → $49 | Initiates | → Overweight | Get Alert |
| 07/15/2022 | Buy Now | -8.26% | Keybanc | Matthew Mishan53% | → $47 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for PROCEPT BioRobotics (PRCT) stock?
The latest price target for PROCEPT BioRobotics (NASDAQ:PRCT) was reported by Morgan Stanley on February 26, 2025. The analyst firm set a price target for $95.00 expecting PRCT to rise to within 12 months (a possible 85.44% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PROCEPT BioRobotics (PRCT)?
The latest analyst rating for PROCEPT BioRobotics (NASDAQ:PRCT) was provided by Morgan Stanley, and PROCEPT BioRobotics maintained their overweight rating.
When was the last upgrade for PROCEPT BioRobotics (PRCT)?
There is no last upgrade for PROCEPT BioRobotics
When was the last downgrade for PROCEPT BioRobotics (PRCT)?
There is no last downgrade for PROCEPT BioRobotics.
When is the next analyst rating going to be posted or updated for PROCEPT BioRobotics (PRCT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PROCEPT BioRobotics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PROCEPT BioRobotics was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.
Is the Analyst Rating PROCEPT BioRobotics (PRCT) correct?
While ratings are subjective and will change, the latest PROCEPT BioRobotics (PRCT) rating was a maintained with a price target of $105.00 to $95.00. The current price PROCEPT BioRobotics (PRCT) is trading at is $51.23, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.